Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Muira puama (*Ptychopetalum olacoides* or *Ptychopetalum uncinatum*) is a shrub native to the Brazilian Amazon[1][2]. It has been used for centuries in traditional South American medicine as an aphrodisiac and general tonic, reputed to enhance libido and sexual function in both men and women[1][3]. The primary parts used medicinally are the bark and roots, which can be prepared as teas, extracts, capsules, or compresses[2]. In addition to its sexual health uses, muira puama is traditionally used for conditions such as stress, fatigue, joint pain, digestive complaints, and memory problems[2][3]. Scientific evidence for its efficacy is limited and inconclusive; most clinical claims are based on traditional use and preliminary animal or in vitro studies, with no high-quality, large-scale human trials confirming benefit for sexual dysfunction or other indications[3][4]. The exact mechanism of action remains unclear, but some research suggests possible adaptogenic, neuroprotective, and acetylcholinesterase-inhibiting effects[5]. Muira puama is considered a dietary supplement, not a pharmaceutical drug, and is commonly found in health food stores and some compounding pharmacies[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on muira puama.